Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00206466 · ClinicalTrials.gov registry record · Phase 2
Biologic Correlative Taxotere/AC
A Phase 2 study, sponsored by Baylor Breast Care Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT00206466: Completed Phase 2 study, sponsored by Baylor Breast Care Center.
NCT00206466 is a Phase 2 study that has completed, run by Baylor Breast Care Center. The registered enrollment target is 70 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00206466, a Phase 2 study, has completed, sponsored by Baylor Breast Care Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
We are asking you to take part in a research study of biomarkers (characteristics or traits of the genes inside cancer cells). We want to learn if these biomarkers could help us learn how well your breast cancer may respond (improve) to chemotherapy (drugs to treat cancer).
Interventions
- DRUG Taxotere
- DRUG Adriamycin/cytoxan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2002-04 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
What the finished NCT00206466 record still lists
NCT00206466 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Taxotere is the first listed.
NCT00206466 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00206466 about?
NCT00206466 is a clinical study titled "Biologic Correlative Taxotere/AC". We are asking you to take part in a research study of biomarkers (characteristics or traits of the genes inside cancer cells). We want to learn if these biomarkers could help us learn how well your breast cancer may respond (improve) to chemotherapy (drugs to treat cancer).
What is the current status of trial NCT00206466?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2002-04. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00206466?
The interventions under investigation include: Taxotere (DRUG), Adriamycin/cytoxan (DRUG).
Who is sponsoring clinical trial NCT00206466?
This trial is sponsored by Baylor Breast Care Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00206466's enrollment target sits among peer trials
70 937th of 2000 higher than 1,036 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia